Product Information
OMNARIS 50 MCG NASAL SPRAY is a brand product labeled by Covis Pharma US, Inc, priced at $22.5584 per GM under NDC 70515070101. Its NADAC has been published 390 times since Jan 9, 2019.
Strength
50 ug/1
Manufacturer
Covis Pharma US, IncNDC
70515070101
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Last Updated
6/17/2026
Active Ingredients
CICLESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA022004On Market Since
4/23/2018
Price Statistics
The NADAC for OMNARIS 50 MCG NASAL SPRAY has been published 390 times since Jan 9, 2019, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.5584 per GM |
|---|---|
| All-time high | $22.8283 (May 10, 2023) |
| All-time low | $21.4544 (Mar 20, 2019) |
| 52-week high | $22.6232 |
| 52-week low | $22.5439 |
| Median price | $22.5855 |
| Average price | $22.4701 |
| Largest weekly change | +5.0% (Jan 1, 2020) |
| Weeks tracked | 390 |
| Tracking since | Jan 9, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ciclesonide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OMNARIS 50 MCG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for OMNARIS 50 MCG NASAL SPRAY, manufactured by Covis Pharma US, Inc, is $22.5584 per GM (NDC 70515070101), effective Jun 24, 2026.
How has the price of OMNARIS 50 MCG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for OMNARIS 50 MCG NASAL SPRAY has risen 4.6%. It has been tracked across 390 weekly CMS publications since Jan 9, 2019.
What are the highest and lowest recorded NADAC prices for OMNARIS 50 MCG NASAL SPRAY?
Since Jan 9, 2019, the NADAC for OMNARIS 50 MCG NASAL SPRAY has ranged from a low of $21.4544 (Mar 20, 2019) to a high of $22.8283 (May 10, 2023), with a median of $22.5855 per GM.
Are there cheaper alternatives to OMNARIS 50 MCG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OMNARIS 50 MCG NASAL SPRAY, so no direct lower-cost alternative is listed.
Who manufactures OMNARIS 50 MCG NASAL SPRAY?
OMNARIS 50 MCG NASAL SPRAY (NDC 70515070101) is labeled by Covis Pharma US, Inc, and CMS classifies it as a brand product.
Related Drugs
Same classification